Paracetamol injection + Normal Saline injection + Morhpine PCA
Phase 2/3Completed 0 watching 0 views this week📈 Rising
65
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Post-operative Analgesia
Conditions
Post-operative Analgesia
Trial Timeline
Jun 1, 2016 → May 1, 2019
NCT ID
NCT02811991About Paracetamol injection + Normal Saline injection + Morhpine PCA
Paracetamol injection + Normal Saline injection + Morhpine PCA is a phase 2/3 stage product being developed by Jiangsu Hengrui Medicine for Post-operative Analgesia. The current trial status is completed. This product is registered under clinical trial identifier NCT02811991. Target conditions include Post-operative Analgesia.
Hype Score Breakdown
Clinical
22
Activity
15
Company
10
Novelty
7
Community
8
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02811991 | Phase 2/3 | Completed |
Competing Products
18 competing products in Post-operative Analgesia